Evidence map›Paper›PMID 26292654›Full record

ArticleScientific reports2015

CNV Analysis Associates AKNAD1 with Type-2 Diabetes in Jordan Subpopulations.

Rana Dajani, Jin Li, Zhi Wei, Joseph T Glessner, Xiao Chang, Christopher J Cardinale, Renata Pellegrino, Tiancheng Wang, Nancy Hakooz, Yousef Khader and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Copy Number Variations in Neuropsychiatric Disorders.International journal of molecular sciences · 2023
    Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Rana DajaniDepartment of Biology and Biotechnology, Hashemite University, Zarqa, Jordan.
Jin LiCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Zhi WeiDepartment of Computer Science, New Jersey Institute of Technology, Newark, NJ 07102, USA.
Joseph T GlessnerCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Xiao ChangCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Christopher J CardinaleCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Renata PellegrinoCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Tiancheng WangCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Nancy HakoozDepartment of Biopharmaceutics and Clinical Pharmacy Faculty of Pharmacy-University of Jordan, Amman, Jordan.
Yousef KhaderDepartment of Community Medicine, Public Health and Family Medicine, Faculty of Medicine, Jordan University for Science and Technology, Irbid, Jordan.
Amina SheshaniDepartment of Biology and Biotechnology, Hashemite University, Zarqa, Jordan.
Duaa ZandakiDepartment of Biology and Biotechnology, Hashemite University, Zarqa, Jordan.
Hakon HakonarsonCenter for Applied Genomics, Abramson Research Center, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous studies have identified a number of single nucleotide polymorphisms (SNPs) associated with type-2 diabetes (T2D), but copy number variation (CNV) association has rarely been addressed, especially in populations from Jordan. To investigate CNV associations for T2D in populations in Jordan, we conducted a CNV analysis based on intensity data from genome-wide SNP array, including 34 T2D cases and 110 healthy controls of Chechen ethnicity, as well as 34 T2D cases and 106 healthy controls of Circassian ethnicity. We found a CNV region in protein tyrosine phosphatase receptor type D (PTPRD) with significant association with T2D. PTPRD has been reported to be associated with T2D in genome-wide association studies (GWAS). We additionally identified 16 CNV regions associated with T2D which overlapped with gene exons. Of particular interest, a CNV region in the gene AKNA Domain Containing 1 (AKNAD1) surpassed the experiment-wide significance threshold. Endoplasmic reticulum (ER)-related pathways were significantly enriched among genes which are predicted to be functionally associated with human or mouse homologues of AKNAD1. This is the first CNV analysis of a complex disease in populations of Jordan. We identified and experimentally validated a significant CNVR in gene AKNAD1 associated with T2D.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseCase-Control StudiesChromosomes, Human, Pair 1Cohort StudiesDiabetes Mellitus, Type 2DNA Copy Number VariationsExonsHumansJordanPolymerase Chain ReactionPolymorphism, Single NucleotidePrincipal Component AnalysisProteinsReproducibility of ResultsAKNAD1 protein, humanProteins

Identifiers

PMID26292654
PMCPMC4543987

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.